-
NMPA Promulgated the Guidelines for Clinical Safety Literature Evaluation of Marketed Drugs (Interim)
2019-07-18
NMPA organized the formulation of the Guidelines for Clinical Safety Literature Evaluation of Marketed Drugs (Interim), which was issued on June 18, 2019.
-
General Office of the State Council Issued the Key Tasks for Deepening the Reform of the Pharmaceutical and Healthcare System in 2019
2019-07-18
Recently, the General Office of the State Council issued the Key Tasks for Deepening the Reform of the Pharmaceutical and Healthcare System in 2019.
-
The 2018 Drug Review Annual Report released
2019-07-06
The 2018 Drug Review Annual Report was released on July 1,2019.
-
CDE Released the List of the Second Batch of Overseas New Drugs Urgently Needed in Clinical Settings
2019-07-06
On May 29, 2019, NMPA Center for Drug Evaluation issued the Notice on the Issuance of the List of the Second Batch of Overseas New Drugs Urgently Needed in Clinical Settings.
-
2018 Annual Report for Medical Device Registration Released
2019-07-06
On May 31, 2019, NMPA issued the 2018 Annual Report for Medical Device Registration, which consists of five parts, namely, the situation of medical device registration; the acceptance of medical device registration applications; review and approval of medical device registration; review and approval of registration for innovative medical devices and other products; and management of other registration affairs.
-
NMPA Issued 27 Medical Device Industry Standards (Covering YY 0096-2019 Co-60 Teletherapy Unit) and 1 Amendment Form
2019-07-06
After review and approval, NMPA published the YY0096-2019 Co-60 Teletheraphy Unit and other 26 medical device industry standards, as well as the No.1 amendment form for YY0285.3-2017 Intravascular catheters-Sterile and single-use catheters-Part 3:Central venous catheters medical device industry standard on May 31, 2019.